Want to see JP:197A full AI Analyst Report?
Tauns Laboratories, Inc. (197A) Stock Statistics & Valuation Metrics
Total Valuation
Tauns Laboratories, Inc. has a market cap or net worth of JPY 52.45B. The enterprise value is JPY 68.50B.
- Market Cap
- JPY 52.45B
- Enterprise Value
- JPY 68.50B
Share Statistics
Tauns Laboratories, Inc. has 106,813,095 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 106,813,095
- Owned by Insiders
- ―
- Owned by Institutions
- 0.39%
Financial Efficiency
Tauns Laboratories, Inc.’s return on equity (ROE) is 0.28 and return on invested capital (ROIC) is 6.86%.
- Return on Equity (ROE)
- 0.28
- Return on Assets (ROA)
- 0.12
- Return on Invested Capital (ROIC)
- 6.86%
- Return on Capital Employed (ROCE)
- 0.14
- Revenue Per Employee
- 53.02M
- Profits Per Employee
- 20.28M
- Employee Count
- 271
- Asset Turnover
- 0.32
- Inventory Turnover
- 0.97
Valuation Ratios
The current PE Ratio of Tauns Laboratories, Inc. is 9.37. Tauns Laboratories, Inc.’s PEG ratio is -0.59.
- PE Ratio
- 9.37
- PS Ratio
- 3.65
- PB Ratio
- 2.67
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 0.00
- PEG Ratio
- -0.59
Income Statement
In the last 12 months, Tauns Laboratories, Inc. had revenue of 14.37B and earned 5.50B in profits. Earnings per share was 52.28.
- Revenue
- 14.37B
- Gross Profit
- 8.22B
- Operating Income
- 4.20B
- Pretax Income
- 7.90B
- Net Income
- 5.50B
- EBITDA
- 5.33B
- Earnings Per Share (EPS)
- 52.28
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 0
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Tauns Laboratories, Inc. pays an annual dividend of JPY 14.00, resulting in a dividend yield of 5.70%
- Dividend Per Share
- JPY 14.00
- Dividend Yield
- 5.70%
- Payout Ratio
- 15.50%
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- 10.61%
Stock Price Statistics
- Beta
- 0.39
- 52-Week Price Change
- -10.89%
- 50-Day Moving Average
- 510.24
- 200-Day Moving Average
- 496.24
- Relative Strength Index (RSI)
- 34.09
- Average Volume (3m)
- 225.56K
Important Dates
Tauns Laboratories, Inc. upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- Dec 29, 2025
Financial Position
Tauns Laboratories, Inc. as a current ratio of 1.26, with Debt / Equity ratio of 109.47%
- Current Ratio
- 1.26
- Quick Ratio
- 0.85
- Debt to Market Cap
- 0.43
- Net Debt to EBITDA
- 3.32
- Interest Coverage Ratio
- 15.91
Taxes
In the past 12 months, Tauns Laboratories, Inc. has paid 2.40B in taxes.
- Income Tax
- 2.40B
- Effective Tax Rate
- 0.30
Enterprise Valuation
Tauns Laboratories, Inc. EV to EBITDA ratio is 13.15, with an EV/FCF ratio of 0.00.
- EV to Sales
- 4.88
- EV to EBITDA
- 13.15
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 0.00
Balance Sheet
Tauns Laboratories, Inc. has JPY 3.56B in cash and marketable securities with JPY 21.26B in debt, giving a net cash position of -JPY 17.70B billion.
- Cash & Marketable Securities
- JPY 3.56B
- Total Debt
- JPY 21.26B
- Net Cash
- -JPY 17.70B
- Net Cash Per Share
- -JPY 165.67
- Tangible Book Value Per Share
- JPY 150.03
Margins
Gross margin is 61.39%, with operating margin of 29.23%, and net profit margin of 38.24%.
- Gross Margin
- 61.39%
- Operating Margin
- 29.23%
- Pretax Margin
- 54.95%
- Net Profit Margin
- 38.24%
- EBITDA Margin
- 37.13%
- EBIT Margin
- 29.30%
Analyst Forecast
The average price target for Tauns Laboratories, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -22.86%
- EPS Growth Forecast
- -16.43%
Scores
- Smart Score
- ―
- AI Score
- 70
